Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for China Pharma Holdings (CPHI) over the last 12 years, with Q3 2025 value amounting to $158076.0.

  • China Pharma Holdings' Depreciation and Depletion fell 6794.76% to $158076.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $800921.0, marking a year-over-year decrease of 6663.11%. This contributed to the annual value of $2.2 million for FY2024, which is 1419.2% down from last year.
  • Per China Pharma Holdings' latest filing, its Depreciation and Depletion stood at $158076.0 for Q3 2025, which was down 6794.76% from $163503.0 recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Depreciation and Depletion registered a high of $966956.0 during Q3 2021, and its lowest value of $158076.0 during Q3 2025.
  • In the last 5 years, China Pharma Holdings' Depreciation and Depletion had a median value of $636721.0 in 2024 and averaged $569004.2.
  • In the last 5 years, China Pharma Holdings' Depreciation and Depletion surged by 4553.82% in 2021 and then crashed by 7432.11% in 2025.
  • Quarter analysis of 5 years shows China Pharma Holdings' Depreciation and Depletion stood at $701100.0 in 2021, then fell by 10.03% to $630781.0 in 2022, then rose by 0.44% to $633577.0 in 2023, then tumbled by 51.43% to $307741.0 in 2024, then crashed by 48.63% to $158076.0 in 2025.
  • Its last three reported values are $158076.0 in Q3 2025, $163503.0 for Q2 2025, and $171601.0 during Q1 2025.